Publication | Closed Access

Design, synthesis and biological evaluation of bromophenol-thiazolylhydrazone hybrids inhibiting the interaction of translation initiation factors eIF4E/eIF4G as multifunctional agents for cancer treatment

Bioorganic ChemistryTranslation Initiation FactorsMedicineBromophenol-thiazolylhydrazone HybridsAnti-cancer AgentCancer TreatmentDrug DevelopmentPharmacologyBiomolecular EngineeringDrug Discovery